View Clinical Trial (Medical Research Study)


Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients - NCT00806026-75093(Clinical Trial 258630)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup

City:  Plano
State:  
TX
Zip Code: 75093
Conditions: Idiopathic Restless Legs Syndrome
Purpose: This purpose of this study is to investigate the efficacy and tolerability of pregabalin in treating idiopathic RLS patients for up to 12 months.
Study summary:
Criteria: Inclusion Criteria: - idiopathic RLS with the presence of all four clinical manifestations of RLS - RLS symptoms occur predominantly in the evening - RLS history at least 6 months - IRLS => 15 at the beginning and the end of placebo run-in - Have =>15 nights with RLS symptoms in the month prior to screening Exclusion Criteria: - Any secondary RLS - Current augmentation due to RLS treatment - Placebo responders identified during the placebo run-in
Study is available at: Pfizer Investigational Site
Plano, TX 75093
United States

Primary Contact:
Pfizer CT.gov Call Center
Phone: 1-800-718-1021
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.

Data Source: ClinicalTrials.gov
Date Processed: March 22, 2011
Modifications to
this listing:
Only selected fields are shown, please use the link above to view all information about this clinical trial.